March 27, 2017
MDxHealth’s biomarkers for Prostate Cancer test could be used for the aggressive version of the disease
MDxHealth has reported results from a castration resistant prostate cancer (CRPC) treatment study.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
March 27, 2017
Erytech Pharma reports positive results from pancreatic cancer study
Erytech Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, has reported positive topline results from its Phase 2b clinical study evaluating its product candidate, eryaspase (GRASPA), in combination with chemotherapy for the treatment of second-line metastatic pancreatic cancer.
March 24, 2017
Eli Lilly plans to invest $850 million in its U.S. operations in 2017
Eli Lilly plans to invest $850 million in its U.S. operations in 2017, the company said Friday.
March 24, 2017
Paul Ryan pulls AHCA from vote on Friday
House Speaker Paul Ryan pulled the American Health Care Act of 2017 (AHCA) from a vote on Friday, which was designed to repeal the Affordable Care Act of 2010 (ACA), known as Obamacare.
March 24, 2017
‘Harmless’ painkillers associated with increased risk of cardiac arrest
Painkillers considered harmless by the general public are associated with increased risk of cardiac arrest, according to research published today in the March issue of European Heart Journal – Cardiovascular Pharmacotherapy.
March 24, 2017
Novartis, PureTech Health team up for the potential treatment of conditions such as immunosenescence
PureTech Health said on Friday that it will advance with Novartis two clinical-stage programmes targeting the mechanistic target of rapamycin complex 1 (mTORC1) pathway.
March 24, 2017
Digital Pharmacist acquires a mobile app for managing prescriptions
Digital Pharmacist Inc., a digital health company, has acquired PocketRx, a mobile app that allows patients to manage their prescriptions.
March 24, 2017
FDA approves EMD Serono’s rare skin cancer drug
EMD Serono, U.S. company focused on specialty care has received U.S. Food and Drug Administration (FDA) approval for its rare skin cancer drug.
March 23, 2017
Latino population in USA have higher rates of cardio-metabolic diseases
Latino population in the United States of America have higher rates of cardio-metabolic diseases than in rest of the population, said David Kerr, director of Innovation and Research for the William Sansum Diabetes center.
March 23, 2017
Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency
Three of Europe’s top drugmakers face critical verdicts from U.S. regulators next week, with Sanofi <SASY.PA> and Roche <ROG.S> likely to win approvals for two new products, while GlaxoSmithKline <GSK.L> braces for a potential generic rival.